GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ADMA · Jun 30, 2025

ADMA BIOLOGICS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001140361-25-029177General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.99% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

17.33% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

13.80% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

156.96% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

55.11% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

35.08% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

0.85% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

4.07% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History10 statesHistory building

Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20240/7 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20250/9 normalizedLevel 3 Dec 31, 20250/9 normalizedLevel 3 Mar 31, 20267/9 normalizedLevel 3 Jun 30, 20267/9 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Decreased

Previous: 4.09%
Current: 1.99%
Delta: -2.11%

Cash Generation Increased

Previous: -17.14%
Current: 17.33%
Delta: 34.47%

Growth Decreased

Previous: 40.22%
Current: 13.80%
Delta: -26.42%

Inventory Pressure Increased

Previous: 149.99%
Current: 156.96%
Delta: 6.97%

Margin Increased

Previous: 53.22%
Current: 55.11%
Delta: 1.89%

Profitability Increased

Previous: 30.38%
Current: 35.08%
Delta: 4.70%

R And D Intensity Increased

Previous: 0.72%
Current: 0.85%
Delta: 0.13%

Sbc Intensity Increased

Previous: 4.03%
Current: 4.07%
Delta: 0.04%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · ADMA Fundamental State →Transitioned To · ADMA Fundamental State →Transitioned To · ADMA CAPEX_INTENSITY_DECREASED →Transitioned To · ADMA CASH_GENERATION_INCREASED →Transitioned To · ADMA GROWTH_DECREASED →Transitioned To · ADMA INVENTORY_PRESSURE_INCREASED →Transitioned To · ADMA MARGIN_INCREASED →Transitioned To · ADMA PROFITABILITY_INCREASED →Transitioned To · ADMA R_AND_D_INTENSITY_INCREASED →Transitioned To · ADMA SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.